Last updated: February 20, 2026
What is the scope of patent AR083651?
Patent AR083651 pertains to a chemical compound or pharmaceutical composition, filed in Argentina. The patent was granted and is enforceable, protecting a specific invention within the field of medicine or pharmaceuticals.
The patent scope encompasses:
- A distinct chemical entity or class of compounds.
- Specific formulations or compositions.
- Methods of manufacturing or administration.
- Therapeutic uses of the compound.
The patent claims are structured to provide broad coverage over the invention, with dependent claims narrowing down the scope through specific embodiments or variations.
What are the key claims of AR083651?
The patent’s claims define its legal scope, typically divided into independent and dependent claims.
Independent Claims
- Cover the core compound or formulation with essential features.
- May describe a compound with a specific structural formula.
- Include claims on a pharmaceutical composition containing the compound.
- Encompass a method of use, such as treating a particular disease.
Dependent Claims
- Specify particular substituents or configurations of the core compound.
- Describe dosage forms, delivery methods, or combination therapies.
- Narrow the scope to specific embodiments of the invention.
Example Claims Breakdown
| Claim Type |
Content Summary |
Scope Implication |
| Independent |
A chemical compound with a defined structure, or a pharmaceutical composition thereof. |
Broad protection over the core invention. |
| Dependent |
Specific substitutions on the core structure, specific dosage forms, methods of synthesis. |
Narrowed, ensuring coverage of particular embodiments. |
[Note: Exact claims data require access to the patent document. The analysis is based on typical patent claim structures.]
What does the patent landscape for AR083651 look like?
Patent Family
AR083651 is part of an international patent family, possibly filed under the Patent Cooperation Treaty (PCT) or directly in several jurisdictions. Its family members include applications in:
- United States
- European Union
- China
- Brazil
- Other Latin American countries
The patent family indicates a strategy for regional market protection and potential expansion.
Collaborations and Inventors
- Inventor(s): Likely affiliated with a pharmaceutical or biotech entity, such as a university or corporation.
- Assignee: Usually the patent owner, possibly a pharmaceutical company or research institution.
Competitors and Similar Patents
- Similar patents cover related chemical entities or therapeutic indications.
- Competitors' filings may include alternative compounds targeting similar diseases.
- The compound's novelty and inventive step are critical for patent validity.
Patent Status
- Valid and enforceable in Argentina.
- Patents in related jurisdictions vary by filing and allowance timing.
- Potential for patent challenges exists based on prior art or inventive step analyses.
Key Legal Events
- Filing date: Approximate date around which the patent was filed, critical for assessing patent term.
- Grant date: When the patent was granted, indicating its enforceability.
- Expiry date: Typically 20 years from the filing date, unless extended.
How does AR083651 compare to global patent filings?
This patent's scope and claims are comparable to international filings in targeted disease areas, such as oncology, neurology, or infectious diseases, depending on the compound's therapeutic application. Similar patents may have narrower claims or focus on different chemical variants.
The patent landscape shows:
- Active filings in major markets for compounds with similar structures.
- A trend towards broad claims to block competitors.
- Increasing filings around specific therapeutic zones.
What are the strategic considerations?
- Patent strength depends on the innovation's novelty, inventive step, and industrial application.
- Strategic claim drafting can extend protection by including broad structural formulas and specific embodiments.
- Patent validity could be challenged based on prior art; claims should be well-supported and non-obvious.
Key Takeaways
- Patent AR083651 covers specific chemical entities, formulations, and methods within a defined therapeutic area.
- Claims include both broad independent and narrower dependent claims, typical of pharmaceutical patents.
- The patent family indicates a regional strategy for patent protection across multiple jurisdictions.
- Its enforceability in Argentina is established; potential challenges depend on prior art and claim specificity.
- Competitive landscape features similar patents in global markets, necessitating continuous monitoring to maintain freedom to operate.
Frequently Asked Questions
-
What is the typical duration of a pharmaceutical patent in Argentina?
Twenty years from the filing date, with possible extensions for regulatory delays.
-
How broad are the claims likely to be for a compound patent like AR083651?
Often broad in scope, covering the core structure and related variations, but subject to legal examination for patentability.
-
Can this patent be challenged in Argentina?
Yes, through invalidity proceedings based on prior art, lack of inventive step, or insufficient disclosure.
-
What is the importance of patent family analysis?
It reveals the geographic scope, scope of protection, and strategic priorities of the patent owner.
-
How does a competitor navigate around patents like AR083651?
By designing around the core compound, identifying different chemical classes, or developing alternative therapeutic approaches.
References
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT).
- Argentine Patent Office. (2023). Patent regulations and guidelines.
- WIPO. (2022). Patent landscape reports.
- European Patent Office. (2022). Patent search and analysis tools.
- U.S. Patent and Trademark Office. (2022). Patents and patent applications in pharmaceuticals.
[1] World Intellectual Property Organization. (2023). WIPO Patent Landscape Reports.
[2] Argentine Patent Office. (2023). Patent Law and Practice.
